InflaRx (IFRX) Income from Continuing Operations (2016 - 2026)

InflaRx has disclosed Income from Continuing Operations across 11 years of filings, most recently posting 8029644.51 for Q1 2026.

• Income from Continuing Operations for Q1 2026 came in at 8029644.51, up 38.97% year-over-year; the trailing twelve-month figure through Mar 2026 was 2148168770585.59 (up 50646073.6% YoY), and the FY2025 annual result was 53119705.66, down 7.91% from the prior year.
• Income from Continuing Operations came in at 8029644.51 for Q1 2026 at InflaRx, down from 2148199631428.07 in the prior quarter.
• In the past five years, Income from Continuing Operations ranged from a high of 2148199631428.07 in Q4 2025 to a low of 16617096.57 in Q1 2022.
• The 5-year median for Income from Continuing Operations is 9158403.12 (2023), against an average of 167754753286.86.
• Across the five-year window, Income from Continuing Operations slumped 775.54% in 2023 and jumped 4652428.6% in 2025, its largest moves.
• InflaRx's Income from Continuing Operations stood at 7848521.18 in 2022, then plunged by 83.11% to 14371694.11 in 2023, then jumped by 421.28% to 46172733.47 in 2024, then surged by 4652428.6% to 2148199631428.07 in 2025, then slumped by 100.0% to 8029644.51 in 2026.
• The last three Income from Continuing Operations figures came in at 8029644.51 (Q1 2026), 2148199631428.07 (Q4 2025), and 9362408.09 (Q3 2025), per Business Quant data.